Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of perioperative versus post-surgery FOLFIRINOX (irinotecan, oxaliplatin, fluorouracil, and folinic acid) treatment in patients with resectable pancreatic cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    The Netherlands Sweden
  • Study on the Effectiveness of Oxaliplatin or Gemcitabine Chemotherapy in Patients with Resected Pancreatic Cancer Using Standard or Genetic Allocation Methods

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Germany Sweden
  • Study on [68Ga]Ga-FAPI-46 PET/CT Imaging for Better Diagnosis in Patients with Pancreatic and Gastroesophageal Cancer

    Not yet recruiting

    2 1 1 1
    Denmark
  • Study on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria Belgium Czechia France Germany Italy +3
  • Study on Dostarlimab, Vitamin D3, and Drug Combination for Untreated Metastatic Pancreatic Cancer Patients

    Not recruiting

    2 1 1 1
    France
  • Study on the Effects of Calcium Chloride and Bleomycin with Electroporation Techniques for Patients with Unresectable Pancreatic Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Poland
  • Study of Nivolumab alone or combined with Ipilimumab for patients with advanced solid tumors (breast, gastric, pancreatic, lung, bladder, or ovarian cancer)

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    Germany
  • Study on Sonoporation-Enhanced Treatment with Gemcitabine, Nab-Paclitaxel, and FOLFIRINOX for Patients with Inoperable Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Norway
  • Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    France Germany Italy Spain
  • Study on the Effectiveness and Safety of Immunotherapy with Atezolizumab, Bevacizumab, and Tiragolumab for Patients with Metastatic Pancreatic Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Spain